
[Cancer Research 15, 15-18, January 1, 1955]
© 1955 American Association for Cancer Research
Attempts to Influence Resistance to the Walker Carcinoma 256 by Administration of Thorium Dioxide (Thorotrast)*
Louis J. Bernard
,
Arthur M. Dutton
and
Michael Radakovich
( Division of Cancer Research, University of Rochester School of Medicine and Dentistry, Rochester, New York)
- 1. Following strangulation or excision of a primary growth of the Walker carcinoma in Sprague-Dawley rats, there was an enhanced refractoriness to reinoculation of the same tumor. This enhanced refractoriness was effective in preventing growth of a new implant in spite of recurrences from residual primary implants.
- 2. There was no difference between the incidence of resistance following strangulation of a primary tumor and that following surgical excision. The development of resistance did not depend on absorption of an antigen from the autolyzed tumor.
- 3. Thorotrast did not increase the incidence of takes of the tumor at a statistically significant level in these experiments.
- 4. Thorotrast did not affect resistance to second inoculations of tumor following banding of an initial implant.
- 5. No increased incidence of remote metastases from the secondary tumor was found in animals given Thorotrast before or during the growth period of the primary tumor.
- 6. No correlation was found between the histology of the lymphoid organs of animals given Thorotrast and the fate of their tumor grafts.
* This study was supported by a grant from the Anna Fuller Fund.
Public Health Service Research Fellow of the National Cancer Institute.
Statistics Section, Atomic Energy Project.
Received 7/23/54.
Copyright © 1955 by the American Association for Cancer Research.